SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-001168
Filing Date
2017-01-06
Accepted
2017-01-06 17:29:23
Documents
1
Period of Report
2017-01-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v456097_form3.html 3  
1 OWNERSHIP DOCUMENT v456097_form3.xml 3 2688
  Complete submission text file 0001144204-17-001168.txt   4112
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Smith Scott Andrew (Reporting) CIK: 0001614975 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13341 | Film No.: 17515230